San Francisco, California, November 06, 2017: The recent market research report by TMR Research, titled “Clinical Microbiology Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025,” presents a detailed analytical overview of the global clinical microbiology market, envisioning its potential growth path over the period between 2017 and 2025.
The report states that the market will exhibit a promising pace of growth over the said period owing top factors such as the rising set of opportunities across a number of new applications areas and the massive rise in patient pool of a number of chronic and infectious diseases on a global front. The market is also expected to benefit from the rising demand for automation as a way of cutting down human errors that often occur during the manual processing of samples. As such, the demand for automated clinical systems is expected to rise at a brisk pace over the report’s forecast period.
The report segments the market on the basis of criteria such as application, product, diseases, and geography. On the basis of products, the report states that the segment of reagents accounted for a dominant share of the overall market in 2015. The segment is also expected to account for a significant share in the global market over the forecast.
Geographically, the report examines the market for clinical microbiology across regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Of these, the market in North America is likely to remain the top grosser owing to the presence of some of the leading players and the encouraging regulatory scenario. The pacey development scenario of the healthcare infrastructure in countries such as the U.S. and openness towards new technological intervention from the consumer side are also expected to add to the growth opportunities in the North America clinical microbiology market in the next few years.
Europe ranks second in terms of revenue opportunity and is envisioned to retain its stature over the report’s forecast period as well. Well-established healthcare infrastructure, the rising prevalence of infectious diseases, and the rising population of geriatrics are among the key factors to have made Europe one of the key takers of clinical microbiology solutions. In the near future, the market in Asia Pacific is expected to witness speedy expansion on the back of the promising expansion of the microbial testing application in a variety of end-use areas. Speedy attempts made at establishing advanced healthcare infrastructure, the rising prevalence of a variety of chronic conditions, and the rising expenditure on healthcare are expected to be the key factors contributing to the development of the Asia Pacific clinical microbiology market.
The report states that the global clinical microbiology market has few players dominating on the global front. Strategies such as increased focus on research and development activities, increased preference to the rapid introduction of new, improved product varieties, and the introduction of automated products have together contributed towards making the position of the few leading players stronger in the past years. In the next few years, the increased number of new vendors on the global front will increase the intensity of competition. Some of the leading players in the market are Hologic Inc., Danaher Corporation, Bruker Corporation, bioMerieux S.A. Howbeit, Becton Dickinson & Company, and Alere Inc.
Get Sample Brochure of this Report Study